SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $266,000 | -14.7% | 1,900 | -7.5% | 0.01% | +40.0% |
| Q2 2019 | $312,000 | -98.7% | 2,054 | -98.8% | 0.01% | -98.8% |
| Q2 2018 | $23,455,000 | +4350.7% | 177,445 | +897.5% | 0.43% | +7050.0% |
| Q1 2017 | $527,000 | -4.2% | 17,789 | -11.4% | 0.01% | +20.0% |
| Q4 2016 | $550,000 | +34.1% | 20,067 | +57.5% | 0.01% | -44.4% |
| Q3 2015 | $410,000 | -69.4% | 12,741 | -71.7% | 0.01% | -83.6% |
| Q2 2014 | $1,341,000 | -44.2% | 45,000 | -55.0% | 0.06% | -64.5% |
| Q1 2014 | $2,403,000 | +56.0% | 100,000 | +32.3% | 0.16% | +101.3% |
| Q4 2013 | $1,540,000 | +27.4% | 75,572 | +195.2% | 0.08% | +60.4% |
| Q3 2013 | $1,209,000 | – | 25,599 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |